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In a 82-year-old female a 22-mm stented 
Soprano (Sorin Biomedica Cardio, Saluggia, 
Italy), bioprosthesis dysfunction was docu-
mented. Computed tomography angiography 
(CTA) showed diffuse aortic calcifications and the 
presence of an aberrant right subclavian artery or 
arteria lusoria (AL) (Fig. 1A–D). A valve-in-valve 
transcatheter aortic valve implantation (TAVI) 
with a 26-mm Corevalve Evolut R (Medtronic, 
Minneapolis, MN, USA) was performed via 
transfemoral access. Due to blood loss, CTA 
was required; aside a retroperitoneal hematoma, 
a large calcified plaque, previously undetected 
at the thoraco-abdominal passage was unexpect-
edly detected (Fig. 1E, F), causing a 50% caliber 
reduction.
A careful review of a previous CTA suggested 
the migration of a voluminous calcification from 
the aortic arch, likely during system advancement. 
Since the patient was asymptomatic, a conservative 
approach was recommended.
Six months later another CTA confirmed the 
entrapment of the calcified plaque in the descend-
ing aorta (Fig. 1G) without clinical signs of periph-
eral hypoperfusion.
Systemic embolization during TAVI remains 
a major issue and the protective role of filters for cer-
ebral protection is controversial. Peripheral emboli-
zation is considered a “minor” complication, and, in 
the described case, the dimension of plaque caused 
its entrapment without clinical consequences. Its 
fracture could have provoked migration toward 
more “sensible” districts, e.g. causing visceral or 
limb ischemia. With the exponential growth of TAVI, 
nowadays proposed also to treat younger patients 
and lower risk populations, a careful evaluation of 
the embolic risk and the development of dedicated 
algorithms should be advocated.
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Figure 1. Maximum intensity projection (MIP) documents a severely calcified aortic arch (A). multi planar reformation 
(MPR) images show an arteria lusoria (AL) in axial (B) and large calcifications of aortic arch in sagittal (C) and coronal 
(D) views. After transcatheter aortic valve implantation (E), MIP shows the presence of previously undetected calci-
fications at the thoraco-abdominal district (arrow), with a bulk mass entrapped in the descending aorta (computed 
tomography axial scan, F), later confirmed at computed tomography angiography performed at 6-month follow-up 
(coronal view, G). 
